drugset / Trial / NCT04244695

Oral Steroid in Controlling Pain After TKA

NCT04244695 ↗

Phase 4 Unknown 40 enrolled Thammasat University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare efficacy of oral steroid in controlling pain after TKA

Timeline

Start
2019-09-01
Primary completion
2020-09
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg Oral
Subject Dexamethasone Small molecule 16 mg Oral

Indications

No indication recorded.